Public preview. Funding rounds, founders, and growth signals require a free account.
Unlock full profile
Clene Nanomedicine, Inc.
Clene is a clinical-stage biopharmaceutical company developing nanotherapeutic treatments for neurodegenerative diseases by targeting cellular energy impairments using its clean-surfaced, catalytically-active nanocrystal platform.
Series BPharmaSalt Lake City, UT51-200 employees
Total raised
$48.7M
Last round
Equity
$42.5M · Aug 2020
Stage
Series B
Status
Active
Founders & team
Growth signals
Track Clene Nanomedicine, Inc. on FlareSight
Get notified the moment Clene Nanomedicine, Inc. files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.